Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» A tale of two studies: Prescribe Pradaxa 'with caution'? Or rely on FDA's safety backing?
A tale of two studies: Prescribe Pradaxa 'with caution'? Or rely on FDA's safety backing?
A tale of two studies: Prescribe Pradaxa 'with caution'? Or rely on FDA's safety backing?
Submitted by
admin
on November 6, 2014 - 8:58am
Source:
Fierce Pharma Marketing
News Tags:
Pradaxa
Boehringer Ingelheim
FDA
Headline:
A tale of two studies: Prescribe Pradaxa 'with caution'? Or rely on FDA's safety backing?
Do Not Allow Advertisers to Use My Personal information
